Indeed, for instance, after plasminogen treatment, our early preliminary results have shown psychiatric improvements in the cuprizone (CPZ) model, which is a widely used animal model of schizophrenia32, and in patients with neurological diseases who exhibit psychiatric symptoms33. This evidence concerns the gene PLG and nervous system disorder.